Covid-19 alters antibiotic use

  13 January 2022

The long-term impact of the coronavirus pandemic on antimicrobial resistance (AMR) remains difficult to predict. Infectious diseases consultant Professor Alison Holmes said Covid-19 has impacted on antibiotic use in hospitals and across the wider community, but more research is needed to fully assess the extent and implications.

Holmes discussed the subject in detail in her presentation ‘Healthcare associated infection, antibiotic use, drug resistance and Covid-19’, to the 73rd annual congress of the German Society for Hygiene and Microbiology, with a focus on bacterial infections, antibiotic use, hospital-onset Covid infection and how that should be tackled, and healthcare associated infections (HCAI) in individuals with and without Covid-19.

Further reading: Healthcare in Europe
Author(s): Mark Nicholls
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!